carbon monoxide-releasing molecule

carbon monoxide–releasing molecule

,

co–RMs

Any of the compounds that carry controlled amounts of carbon monoxide to cells for therapeutic purposes.
References in periodicals archive ?
Poole, "Interaction of the carbon monoxide-releasing molecule Ru (CO)3Cl(glycinate) (CORM-3) with Salmonella enterica serovar Typhimurium: in situ measurements of carbon monoxide binding by integrating cavity dual-beam spectrophotometry," Microbiology, vol.
Mancio-Silva et al., "A novel carbon monoxide-releasing molecule fully protects mice from severe malaria," Antimicrobial Agents and Chemotherapy, vol.
Pol, "Treatment with a carbon monoxide-releasing molecule inhibits chronic inflammatory pain in mice: nitric oxide contribution," Psychopharmacology, vol.
Cepinskas, "Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction," Free Radical Biology and Medicine, vol.
Clark, "Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule," Circulation Research, vol.
Motterlini, "Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule," American Journal of Physiology-Renal Physiology, vol.
Han, "Renoprotective effects of carbon monoxide-releasing molecule 3 in ischemia-reperfusion injury and cisplatin-induced toxicity," Transplantation Proceedings, vol.
Hammad et al., "CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule," FASEB Journal, vol.
Motterlini, "Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities," Circulation Research, vol.
5 May 2017 - US-based carbon monoxide therapies developer Proterris, Inc and Portuguese Carbon Monoxide-Releasing Molecules (CORMs) therapies developer Alfama, Inc.
Foresti, "Therapeutic applications of carbon monoxide-releasing molecules," Expert Opinion on Investigational Drugs, vol.
Full browser ?